Ulm Centre of Peptide Pharmaceuticals (U-PEP)
The Ulm Centre of Peptide Pharmaceuticals at Ulm University is a link between science and industry. Scientists from the Institutes of Molecular Virology, Organic Chemistry III and Pharmaceutical Biotechnology are working together at U-PEP to develop innovative and safe pharmaceuticals built on peptide- or protein-based active ingredients, pairing the scientific and medical sectors’ expertise. U-PEP drives long-term scientific discourse at a high level and relies on the "science of short distances".
Peptides made up of amino acids play an increasingly important role in the pharmaceutical industry. As an interdisciplinary centre, U-PEP is a link between different research disciplines, providing optimal conditions for the isolation, identification, synthesis, optimisation and (biotechnical) production of peptide- and protein-based drugs.
U-PEP research unites all components of modern life sciences. As a link between science and industry, U-PEP is a partner for university and industrial research groups and collaborations.
Together with Harvard Medical School, the Centre for Molecular and Biomolecular Informatics, Jülich Research Centre and Lead Pharma Holding B.V., U-PEP is currently researching alternative antibiotics. Research project ‘C-Terminal Processing Protease Inhibitors as Antibacterial Drugs’ examines peptides as a potential new generation of antibiotics. These antibiotics are said to "disarm" pathogens instead of killing them quickly, as with conventional antibiotics.